← Leaderboards
Anthony Atala
Wake Forest University Health Sciences
$9,615,399
Attributed
$11,931,313
Total exposure
12
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,347,027 · 13
By mechanism
R01$8,434,665 · 4
T32$1,490,501 · 1
U2C$1,415,714 · 1
P41$1,350,824 · 1
P50$540,323 · 5
M01$115,000 · 1
Top collaborators
- David B Agus4 shared
- Shay Soker4 shared
- Ronald J Falk3 shared
- Thomas L Ortel3 shared
- James Koudy Williams3 shared
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- Jennifer Hipp$153,147
- James Koudy Williams$9,746,880
Others in their field
Top investigators on “Tissue Engineering”
- Wesley Ian Sundquist · Utah State Higher Education System--University Of Utah$47,918,780
- Robert Stanley Sherwin · Yale University$43,700,325
- Gordana Vunjak-Novakovic · Tufts University Medford$36,226,687
- Louis J. Picker · Oregon Health And Science University$34,577,072
- Karl Alexander Deisseroth · Stanford University$34,039,874
- David S Perlin · Hackensack University Medical Center$33,316,814
Research focus
Tissue EngineeringCellsRegenerative MedicineIn VitroProductionOrganIn VivoTissuesStructureAffectScaffoldEngineeringComplexTechnologyCell TransplantationGrowthBaseBiomedical EngineeringPhenotypeResearch StudyAutologousImplantDimensionsCell Type
Grant awards (45)
U2C/TL1 NC KUH TRIO Program$488,177
U2C · FY2025 · DK
Bioengineered Tissues For Uterine Reconstruction$404,592
R01 · FY2025 · HD · contact PI
Bioengineered Tissues For Uterine Reconstruction$497,469
R01 · FY2024 · HD · contact PI
U2C/TL1 NC KUH TRIO Program$439,360
U2C · FY2024 · DK
Studies in Translational Regenerative Medicine$199,623
T32 · FY2024 · EB · contact PI
Bioengineered Tissues For Uterine Reconstruction$496,936
R01 · FY2023 · HD · contact PI
U2C/TL1 NC KUH TRIO Program$488,177
U2C · FY2023 · DK
Studies in Translational Regenerative Medicine$165,542
T32 · FY2023 · EB · contact PI
Bioengineered Tissues For Uterine Reconstruction$589,817
R01 · FY2022 · HD · contact PI
Studies in Translational Regenerative Medicine$182,850
T32 · FY2022 · EB · contact PI
Bioprinting Patterning for Cell-Laden Constructs$265,824
P41 · FY2021 · EB · contact PI
Studies in Translational Regenerative Medicine$199,696
T32 · FY2021 · EB · contact PI
Bioprinting Patterning for Cell-Laden Constructs$271,250
P41 · FY2020 · EB · contact PI
Studies in Translational Regenerative Medicine$74,679
T32 · FY2020 · EB · contact PI
Bioprinting Patterning for Cell-Laden Constructs$271,250
P41 · FY2019 · EB · contact PI
Bioprinting Patterning for Cell-Laden Constructs$271,250
P41 · FY2018 · EB · contact PI
Studies in Translational Regenerative Medicine$47,886
T32 · FY2018 · EB · contact PI
Bioprinting Patterning for Cell-Laden Constructs$271,250
P41 · FY2017 · EB · contact PI
Studies in Translational Regenerative Medicine$160,322
T32 · FY2017 · EB · contact PI
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis$560,735
R01 · FY2016 · CA
Studies in Translational Regenerative Medicine$184,144
T32 · FY2016 · EB · contact PI
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis$577,096
R01 · FY2015 · CA
Studies in Translational Regenerative Medicine$183,979
T32 · FY2015 · EB · contact PI
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis$557,736
R01 · FY2014 · CA
Studies in Translational Regenerative Medicine$91,780
T32 · FY2014 · EB · contact PI
(PQB6)An Integrative Computational and Bioengineered Tissue Model of Metastasis$590,138
R01 · FY2013 · CA
Insulin Producing Cells from Amniotic Stem Cells for Diabetes Therapy$1,025,080
R01 · FY2009 · EB · contact PI
Insulin Producing Cells from Amniotic Stem Cells for Diabetes Therapy$38,766
R01 · FY2009 · EB · contact PI
Insulin Producing Cells from Amniotic Stem Cells for Diabetes Therapy$1,025,080
R01 · FY2008 · EB · contact PI
Insulin Producing Cells from Amniotic Stem Cells for Diabetes Therapy$111,000
R01 · FY2008 · EB · contact PI
Insulin Producing Cells from Amniotic Stem Cells for Diabetes Therapy$1,058,000
R01 · FY2007 · EB · contact PI
The Harvard Urologic Research Center$157,511
P50 · FY2007 · DK · contact PI
PROJECT 1$188,491
P50 · FY2006 · DK · contact PI
PROJECT 1$194,321
P50 · FY2005 · DK
PROJECT 1$0
P50 · FY2004 · DK
BIOENGINEERING OF BLADDER TISSUES$151,121
R01 · FY2003 · DK
BIOENGINEERING OF BLADDER TISSUES$74,434
R01 · FY2003 · DK
Urethral Tissue Bioengineering$0
P50 · FY2003 · DK
BIOENGINEERING OF BLADDER TISSUES$225,555
R01 · FY2002 · DK
MOLECULAR GENETIC ANALYSIS OF VESICOURETERAL REFLUX IN PATIENTS &THEIR FAMILIES$28,750
M01 · FY2002 · RR
BIOENGINEERING OF BLADDER TISSUES$225,555
R01 · FY2001 · DK
MOLECULAR GENETIC ANALYSIS OF VESICOURETERAL REFLUX IN PATIENTS &THEIR FAMILIES$28,750
M01 · FY2001 · RR
MOLECULAR GENETIC ANALYSIS OF VESICOURETERAL REFLUX IN PATIENTS &THEIR FAMILIES$28,750
M01 · FY2001 · RR
BIOENGINEERING OF BLADDER TISSUES$225,555
R01 · FY2000 · DK
MOLECULAR GENETIC ANALYSIS OF VESICOURETERAL REFLUX IN PATIENTS &THEIR FAMILIES$28,750
M01 · FY2000 · RR